基本信息
浏览量:0
职业迁徙
个人简介
Research Synopsis
Keywords: Cancer, Cell biology, Glucocorticoid receptors, Ovarian cancer; androgen receptor, steroid hormones, prostate cancer, endometrial receptivity, reproductive endocrinology
Detailed Description: Epithelial ovarian cancer (EOC) affects nearly a quarter million women worldwide each year and is the most lethal gynecological cancer in North America. Once thought to arise from a common cell of origin, studies now indicate the various histotypes of EOC may arise from non-ovarian cells, associate with distinct gene mutations, and diverge significantly in their clinical course. Of the various EOC histotypes, high-grade serous ovarian carcinoma (HGSOC) is the most prevalent and lethal. Compelling evidence provided by observational pathology studies and gene expression approaches support the paradigm-shifting concept that the cell of origin for HGSOC lies within the fallopian tube epithelium. Women with a germline mutation in BRCA1 or 2 are at the greatest risk of developing HGSOC. Additional identified risk factors for HGSOC are associated with an increased number of lifetime ovulatory events. We have found that gene expression profiles of non-malignant fallopian tube epithelial cells isolated from BRCA mutation carriers resemble that of HGSOC rather than non-malignant fallopian tube epithelial cells from control patients. This pattern is most pronounced in the luteal phase of the menstrual cycle and involves a proinflammatory signature. Ongoing studies are investigating the role of glucocorticoid receptors and downstream targets that may play a role in disease predisposition.
Studies from our laboratory have also shown that androgens alter the growth-inhibitory action of TGFβ in malignant and non-malignant ovarian epithelial cells. In recent work, we have identified a novel protein that may mediate these actions of androgen. Ongoing studies are investigating the role of this protein on TGFβ signaling and cross talk with other signaling pathways in the context of ovarian cancer.
Androgen-receptor associated protein 70 (ARA70) or NCoA4 was initially described as an androgen receptor specific co-activator. We have shown that NCoA4 is upregulated in EOC whereas a splice variant is expressed in invasive ductal breast carcinoma. We have also demonstrated that NCoA4 functions as a co-activator for the aryl hydrocarbon receptor, also known as the dioxin receptor. In recent work, we have found that NCoA4 interacts with tubulin and localizes to microtubules and particularly to the mitotic spindle. We are presently exploring the possibility that this novel protein plays a critical role in mitotic spindle formation, perhaps affecting cytokinesis.
Keywords: Cancer, Cell biology, Glucocorticoid receptors, Ovarian cancer; androgen receptor, steroid hormones, prostate cancer, endometrial receptivity, reproductive endocrinology
Detailed Description: Epithelial ovarian cancer (EOC) affects nearly a quarter million women worldwide each year and is the most lethal gynecological cancer in North America. Once thought to arise from a common cell of origin, studies now indicate the various histotypes of EOC may arise from non-ovarian cells, associate with distinct gene mutations, and diverge significantly in their clinical course. Of the various EOC histotypes, high-grade serous ovarian carcinoma (HGSOC) is the most prevalent and lethal. Compelling evidence provided by observational pathology studies and gene expression approaches support the paradigm-shifting concept that the cell of origin for HGSOC lies within the fallopian tube epithelium. Women with a germline mutation in BRCA1 or 2 are at the greatest risk of developing HGSOC. Additional identified risk factors for HGSOC are associated with an increased number of lifetime ovulatory events. We have found that gene expression profiles of non-malignant fallopian tube epithelial cells isolated from BRCA mutation carriers resemble that of HGSOC rather than non-malignant fallopian tube epithelial cells from control patients. This pattern is most pronounced in the luteal phase of the menstrual cycle and involves a proinflammatory signature. Ongoing studies are investigating the role of glucocorticoid receptors and downstream targets that may play a role in disease predisposition.
Studies from our laboratory have also shown that androgens alter the growth-inhibitory action of TGFβ in malignant and non-malignant ovarian epithelial cells. In recent work, we have identified a novel protein that may mediate these actions of androgen. Ongoing studies are investigating the role of this protein on TGFβ signaling and cross talk with other signaling pathways in the context of ovarian cancer.
Androgen-receptor associated protein 70 (ARA70) or NCoA4 was initially described as an androgen receptor specific co-activator. We have shown that NCoA4 is upregulated in EOC whereas a splice variant is expressed in invasive ductal breast carcinoma. We have also demonstrated that NCoA4 functions as a co-activator for the aryl hydrocarbon receptor, also known as the dioxin receptor. In recent work, we have found that NCoA4 interacts with tubulin and localizes to microtubules and particularly to the mitotic spindle. We are presently exploring the possibility that this novel protein plays a critical role in mitotic spindle formation, perhaps affecting cytokinesis.
研究兴趣
论文共 188 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Heather Shapiro,Danielle C. Bentley, G. Scot Hamilton, Pat Chronis-Brown, Avrum I. Gotlieb,Theodore J. Brown
F&S Reports (2023)
Heather Shapiro,Danielle C Bentley, G Scot Hamilton, Pat Chronis-Brown, Avrum I Gotlieb,Theodore J Brown
F&S reportsno. 1 (2023): 123-124
Heather Shapiro,Theodore J. Brown, Pat Chronis-Brown, G. Scot Hamilton,Danielle C. Bentley, Rita Kandel, Avrum I. Gotlieb
F&S Reportsno. 3 (2023): 262-269
Cell metabolismno. 1 (2023): 130-143.e5
JOURNAL OF OVARIAN RESEARCHno. 1 (2022): 1-13
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn